Thesis (Ph.D.)--Stanford University, 2002. / Adviser: Sylvia Yanagisako. Includes bibliographical references.

Thesis (M. Sc.)--University of Hong Kong, 2001. / Includes bibliographical references (leaves 56-57).

Thesis (M. P. H.)--University of Hong Kong, 2007.

Thesis (M. P. H.)--University of Hong Kong, 2007. / Also available in print.

Thesis (M.Sc.)--University of Hong Kong, 2001. / Includes bibliographical references (leaves 56-57). Also available in print.

I. Exploring the prevalence of Chinese medicine. A questionnaire survey was conducted in 100 healthy people and 82 breast cancer patients. The survey showed that a very high prevalence of using Chinese medicine as a health supplementary was found among the healthy people (98%). The prevalence was even higher among breast cancer patients (99%). / II. Evidence based evaluation of the efficacy of Chinese medicine . The public's increasing use of Chinese medicine has added urgency to the need of examining the efficacy and safety of Chinese medicine practice and product. In order to understand the efficacy of Chinese medicine and the feasibility of standard research methodology of evidence-based medicine, two clinical trials were conducted in 100 healthy subjects and 82 breast cancer patients using the preparation contains YunZhi (Coriolus versicolor ) and Danshen (Radix Salviae miltorrhizae). The findings showed that the YunZhi and Danshen compound significantly enhanced the quality of life in healthy and some breast cancer subjects with reference to physical, emotional and health transitions. / III. Role of Chinese medicine in our health care system. Chinese medicine has been used for more than 3000 years in China and there have been numerous reports of efficacy. Chinese medicine would be offering solutions to some medical condition, where modern medicine yet failed to provide effective solution. Examples included chronic diseases, viral infections, allergies, derangements, cancers, etc. The health care system could provide the public alternative choices of medical treatment related to Chinese medicine as valuable supplements to modern medicine. (Abstract shortened by UMI.) / The use of alternative medicine has become increasingly popular around the world, mainly because of growing interest in holistic medicine and natural methods of healing. The Public is becoming increasingly aware of the limits of Modern medicine, and is looking forward to the possible benefits of alternative medicine. Because of the lack of perfect confidence on Modern medicine due to the unclear role of health promotion and unsatisfactory outcome of chronic diseases, people turn to alternative medicine. In Hong Kong, alternative medicine in reality, means very much Chinese medicine. A better understanding of the prevalence of Chinese medicine is needed in order to determine what needs to be done to improve the safety and efficacy of Chinese medicine with regard to its service role in the Health Care System. This thesis is structured to assess the popularity and peoples' attitude of Chinese medicine in Hong Kong; to assess the validity of evidence-based approach in the evaluation of the efficacy of Chinese medicine; and to explore the role of Chinese medicine in health care in the Health Care System. / by Wong Lai-Yi. / "January 2005." / Advisers: Ping-Chung Leung; Jin-Ling Tang. / Source: Dissertation Abstracts International, Volume: 67-01, Section: B, page: 0219. / Thesis (Ph.D.)--Chinese University of Hong Kong, 2005. / Includes bibliographical references (p. 175-212). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Electronic reproduction. [Ann Arbor, MI] : ProQuest Information and Learning, [200-] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstracts in English and Chinese. / School code: 1307.

張海藝. / "2009年1月". / "2009 nian 1 yue". / Thesis (M.Phil.)--Chinese University of Hong Kong, 2008. / Includes bibliographical references (leaves 283-284). / Abstracts in Chinese and English. / Zhang Haiyi. / Chapter 第一章 --- 導論 / Chapter 第一節 --- 「中西醫滙通派」的界定及硏究對象選取 --- p.1 / Chapter 第二節 --- 本文的硏究方法及目的 --- p.4 / Chapter 第四節 --- 「中西醫滙通派」的硏究槪況回顧 --- p.6 / Chapter 第二章 --- 唐宗海的黃帝內經思想 / Chapter 第一節 --- 人物及其著作介紹 --- p.8 / Chapter 第二節 --- 唐宗海的中西醫滙通觀 --- p.9 / Chapter 第三節 --- 唐宗海的內經思想 --- p.10 / Chapter 第四節 --- 中西醫滙通觀在內經的體現 --- p.11 / Chapter 第三章 --- 張鍚純的黃帝內經思想 / Chapter 第一節 --- 人物及其著作介紹 --- p.13 / Chapter 第二節 --- 張鍚純的中西醫滙通觀 --- p.13 / Chapter 第三節 --- 張鍚純的內經思想 --- p.14 / Chapter 第四節 --- 中西醫滙通觀在內經的體現 --- p.15 / Chapter 第四章 --- 惲鐵樵的黃帝內經思想 / Chapter 第一節 --- 人物及其著作介紹 --- p.17 / Chapter 第二節 --- 惲鐵樵的中西醫滙通觀 --- p.17 / Chapter 第三節 --- 惲鐵樵的內經思想 --- p.19 / Chapter 第四節 --- 中西醫滙通觀在內經的體現 --- p.20 / Chapter 第五章 --- 三醫家的思想比較 / Chapter 第一節 --- 對《黃帝內經》的評價 --- p.21 / Chapter 第二節 --- 中西醫滙通觀 --- p.21 / Chapter 第三節 --- 中西醫滙通在《內經》之體現 --- p.22 / Chapter 第六章 --- 滙通的再思 / Chapter 第一節 --- 滙通的意思 --- p.24 / Chapter 第二節 --- 三醫位滙通派醫家對現今中醫學發展的啓示 --- p.25 / Chapter 第七章 --- 總結 --- p.26

A safety study was then carried out in VIVO III normal pregnant mice. The most commonly used single herb, Largehead Atractylodes Rhizome, at relevant clinical doses was administered orally to the pregnant animals at different or throughout gestational periods, beneficial and adverse effects on both mothers and offspring were studied. At higher clinical dosage, significant decreased maternal weight, fetal/neonatal growth and weight; and significant increased incidences of fetal resorption, congenital caudal regression and hip dysplasia were recorded . Bone CT examination and skeleton staining confirmed congenital skeleton abnormality, including shoulder joint dislocation, congenital absence of ulna and distal digits, oligodactyly, long bone shortening, congenital hip dislocation and caudal regression In vitro whole embryo culture confirmed that Largehead Atractylodes Rhizome induced abnormal limb development during early development. Molecular study suggested the effects of Largehead Atractylodes Rhizome on Tbx suppression for early limb development. / For more than 3,000 years of history, Traditional Chinese Medicine has been used in pregnant women. Nowadays, it is principally applied in Mainland China but has become more and more widely used worldwide to promote both mothers ' and fetuses ' health and treat common pregnancy disorders. / Over 3,000 publications were identified and selected to assess Chinese medicines for pregnancy, including their indications, contraindications, formulae , individual medicines, regimes, effectiveness , efficacy, safety, adverse effects and toxicity. Amongst all clinical applications, threatened miscarriage was the most common clinical indication. Shou Tai Pill, containing 4 major herbal medicines Chinese Dodder Seed, Chinese Taxillus Twig, Donkey-hide Glue, and Himalayan Teasel Root, was the most commonly used formula in preventing miscarriage and promoting pregnancy. The top 10 most frequently prescribed single herbal medicines in wide variety of formulas were identified. The average clinical dose for each medicine ranged from 6g to 28g daily, however the dosage of Chinese medicines was not significantly correlated with its overall efficacy. Randomized controlled trials evaluating the effectiveness of the medicines were selected for meta-analysis. The results showed Chinese medicines in combination with other pharmaceuticals were more effective to improve the clinical outcomes of threatened miscarriages than other pharmaceuticals. No specific safety problem was reported, but potential adverse and toxic effects on reproductive system by certain medicines were identified from other publications. / To date, no data are available to provide an overview of Chinese medicines in pregnancy. In the first part of this study, the clinical applications, and therapeutic effects and safety of Chinese medicines for pregnancy were reviewed and studied. In the second part of this study, the safety of most commonly used Chinese medicine during pregnancy was studied in pregnancy animal models, in vivo and in vitro. / Li, Lu. / Adviser: Wang Chi Chiu. / Source: Dissertation Abstracts International, Volume: 73-04, Section: B, page: . / Thesis (Ph.D.)--Chinese University of Hong Kong, 2011. / Includes bibliographical references (leaves 299-330). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Electronic reproduction. [Ann Arbor, MI] : ProQuest Information and Learning, [201-] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstract also in Chinese.

朱少佳. / "2009年9月". / "2009 nian 9 yue". / Thesis (M.Phil.)--Chinese University of Hong Kong, 2009. / Includes bibliographical references (leaves 75-85). / Abstracts in Chinese and English. / Zhu Shaojia. / 致謝辭 --- p.i / 中文摘要 --- p.iii / 英文搞要 --- p.v / 中英名詞對照表 --- p.viii / 目錄 --- p.ix / 表目錄 --- p.xii / 圖表目錄 --- p.xiv / Chapter 第壹章 --- 引言 --- p.1 / Chapter 第一節 --- 功能性消化不良的歷史源流與進展 --- p.1 / Chapter 1 --- FD流行病學硏究 --- p.1 / Chapter 2 --- FD帶來的經濟負擔與健康影響 --- p.2 / Chapter 3 --- FD診斷標準的發展 --- p.2 / Chapter 甲 --- Colin-Jones診斷標準 --- p.2 / Chapter 乙 --- 羅馬I診斷標準 --- p.2 / Chapter 丙 --- 羅馬II診斷標準 --- p.3 / Chapter 丁 --- 羅馬III診斷標準 --- p.4 / Chapter 第二節 --- FD的病理生理學硏究 --- p.5 / Chapter 1 --- 胃酸分泌量異常 --- p.5 / Chapter 2 --- 胃動力障礙 --- p.6 / Chapter 甲 --- 胃排空延遲 --- p.6 / Chapter 乙 --- 近端胃受容性及收縮異常 --- p.6 / Chapter 丙 --- 遠端胃部與十二指腸活動異常 --- p.7 / Chapter 丁 --- 胃電節律紊亂 --- p.7 / Chapter 3 --- 胃感覺異常 --- p.8 / Chapter 4 --- 感染與發炎 --- p.8 / Chapter 甲 --- 幽門螺旋菌 --- p.8 / Chapter 乙 --- 急性細菌性胃腸炎 --- p.9 / Chapter 第三節 --- 中醫學對FD的認識 --- p.9 / Chapter 第四節 --- FD的飲食及生活習慣建議 --- p.11 / Chapter 第五節 --- 可能影響FD的因素 --- p.14 / Chapter 1 --- 年齡 --- p.11 / Chapter 2 --- 性 别 --- p.11 / Chapter 3 --- 社會經濟狀況或失業 --- p.11 / Chapter 4 --- 教育程度 --- p.12 / Chapter 5 --- 輪班 --- p.12 / Chapter 6 --- 精神心理狀態 --- p.12 / Chapter 7 --- 飲食生活習慣 --- p.12 / Chapter 第六節 --- FD的治療 --- p.14 / Chapter 1 --- FD西醫藥的治療 --- p.14 / Chapter 2 --- FD中醫藥的治療 --- p.15 / Chapter 第七節 --- 硏究目的 --- p.17 / Chapter 第貳章 --- 硏究問卷與方法 --- p.17 / Chapter 第一節 --- 定義 --- p.17 / Chapter 1 --- 嚴重消化不良症狀定義 --- p.17 / Chapter 2 --- 工作、生活、飲食習慣定義 --- p.17 / Chapter 3 --- 可能影響FD的因素、相關因素、較強相關因素定義 --- p.17 / Chapter 4 --- 公立專科門診FD病人、社區未經檢查FD病人、健康人定義… --- p.17 / Chapter 第二節 --- 問卷 --- p.18 / Chapter 1 --- 功能性消化不良與有關因素問卷 --- p.19 / Chapter 2 --- 中醫胃病症狀觀察表格 --- p.19 / Chapter 第三節 --- 調查方法 --- p.19 / Chapter 1 --- 電話訪問調查 --- p.20 / Chapter 2 --- 公立專科門診病人調查 --- p.21 / Chapter 甲 --- 病例入選標準 --- p.22 / Chapter 乙 --- 病例排除標準 --- p.22 / Chapter 3 --- 統計學分析方法 --- p.22 / Chapter 第叁章 --- 結果 --- p.24 / Chapter 第一節 --- 電話訪問調查 --- p.24 / Chapter 1 --- 香港FD人口患病率 --- p.24 / Chapter 2 --- FD相關因素調查 --- p.25 / Chapter 甲 --- FD羅馬II診斷標準的相關因素調查 --- p.26 / Chapter 乙 --- FD羅馬III診斷標準的相關因素調查 --- p.33 / Chapter 丙 --- FD羅馬II與FD羅馬III診斷標準相關因素比較 --- p.39 / Chapter 丁 --- 嚴重消化不良症狀的相關因素 --- p.40 / Chapter 第二節 --- 公立專科門診病人調查 --- p.48 / Chapter 1 --- FD病人中醫辨證分型分析 --- p.57 / Chapter 2 --- FD西醫分型分佈規律 --- p.60 / Chapter 3 --- FD病人的幽門螺旋菌感染分佈 --- p.61 / Chapter 4 --- 社區未經檢查FD病人與公立專科門診FD病人比較 --- p.62 / Chapter 5 --- 公立專科門診FD病人、社區未經檢查FD病人與健康人比較 --- p.65 / Chapter 第肆章 --- 總結及討論 --- p.67 / 參考文獻 --- p.75 / 附錄 --- p.86 / 附錄甲：功能性消化不良與相關因素問卷 --- p.87 / 附錄乙：中醫胃病症狀觀察表格 --- p.98 / 附錄丙：電話調查問卷 --- p.104 / 附錄丁 ：病人資料及同意書 --- p.120 / 附錄戊：因素變數列表 --- p.124 / 附錄己：100例FD病人舌象、脈象及其他特徵性症狀記錄…… --- p.128

沈成豪. / "2007年8月". / 論文(哲學碩士)--香港中文大學, 2007. / 參考文獻(leaves 57-65). / "2007 nian 8 yue". / Abstract also in English. / Shen Chenghao. / Lun wen (Zhe xue shuo shi)--Xianggang Zhong wen da xue, 2007. / Can kao wen xian (leaves 57-65). / 目錄 --- p.2 / 表格目錄 --- p.5 / 感謝 --- p.6 / 摘要 --- p.7 / Abstract --- p.8 / 目的 --- p.9 / Chapter 一. --- 背景 --- p.9 / Chapter 1. --- 消化不良的槪念 --- p.9 / Chapter 2. --- 功能性消化不良流行病學資料 --- p.11 / Chapter 3. --- 功能性消化不良的醫療開支以及相關的經濟損失 --- p.12 / Chapter 4. --- 功能性消化不良的病理 --- p.13 / Chapter 5. --- 功能性消化不良的藥物治療 --- p.16 / Chapter 二. --- 中醫藥與功能性消化不良 --- p.17 / Chapter 三. --- 功能性消化不良的中醫硏究文獻回顧 --- p.20 / Chapter 1. --- 功能性消化不良與中醫證型的相關硏究 --- p.20 / Chapter 2. --- 功能性消化不良的中醫臨床辨證規律 --- p.20 / Chapter 3. --- 中醫脾胃病專家對功能性消化不良的見解 --- p.25 / Chapter 4. --- 功能性消化不良的中醫診療標準 --- p.26 / Chapter 5. --- 小結 --- p.27 / 臥床資料 --- p.28 / Chapter 一. --- 病例選擇標準 --- p.28 / Chapter 1. --- 功能性消化不良的西醫診斷標準 --- p.28 / Chapter 2. --- 功能性消化不良的中醫證候診斷標準 --- p.28 / Chapter 二. --- 硏究對象 --- p.31 / Chapter 1. --- 病例來源 --- p.31 / Chapter 2. --- 病例入選標準 --- p.31 / Chapter 3. --- 病例排除標準 --- p.31 / Chapter 三. --- 觀察方法 --- p.32 / Chapter 四. --- 數據處理 --- p.32 / Chapter 五. --- 統計學處理 --- p.33 / 結果 --- p.34 / Chapter 一. --- 一般流行病學資料 --- p.34 / Chapter 二. --- 功能性消化不良亞型的分布 --- p.36 / Chapter 三. --- 功能性消化不良的中醫證型分類硏究 --- p.37 / Chapter 1. --- 功能性消化不良中醫證型分布 --- p.37 / Chapter 2. --- 性別與中醫證型分布的關係 --- p.38 / Chapter 3. --- 年齢與中醫證型分布的關係 --- p.40 / Chapter 4. --- 病程與中醫證型分布的關係 --- p.42 / Chapter 5. --- 功能性消化不良的亞型與中醫證型硏究 --- p.44 / Chapter 四. --- 功能性消化不良的症狀分析 --- p.46 / Chapter 1. --- 胃脘部症狀分析 --- p.46 / Chapter 2. --- 胃脘其他症狀分析 --- p.47 / 討論 --- p.48 / 結論 --- p.55 / 展望及日後工作 --- p.56 / 參考文獻 --- p.57 / 附錄一：中醫胃病症狀觀察表格 --- p.66 / 附錄二：功能性消化不良中醫證候硏究病人同意書 --- p.73